Form 4: Mind Medicine (MindMed) Executive Sells Shares
Insider Transaction (Form 4)
Matthew T. Wiley, Chief Commercial Officer of Mind Medicine (MindMed) Inc., sold 3,097 shares of common stock on September 25, 2026 for $36.57 per share.
Summary
- Open-market sale: disposed of 3,097 Common Shares at $36.57 ($113,257) on September 25, 2026; holds 359,036 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $113,257 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Matthew T. Wiley — Officer (Chief Commercial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-25 | Open-market sale | Common Shares | 3,097 | $37 | $113.3K | 359,036 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-25 | Open-market sale (3,097 shares) |
Keywords
insider transaction, Form 4, DFTX, Definium Therapeutics, Inc., bearish, Matthew T. Wiley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.